The Bio-Industrial Liaison Committee (BILC) exists to provide a forum for industry members to provide input and guidance to the Society's Board of Directors on matters pertaining to process development and manufacturing and product development and clinical development of therapeutics and devices. The duties of the BILC include recommending and organizing sessions relevant to the industry and the society for the Annual Meeting, providing input into draft guidance prepared by the Society and serving as a liaison to other members of industry. The Chair of the BILC is appointed by the President-Elect.
The Clinical Trials and Regulatory Affairs Committee shall be responsible for monitoring the regulatory environment in the field of gene and cell therapy and shall develop position statements as needed and recommend those statements to the President and Board of Directors. In addition, the committee will develop suggested programs related to this area for presentation at the Annual Meeting and submit them to the Program Committee for review and approval. The committee shall also develop programs at the request of the ASGCT President and Board of Directors for presentation as stand alone meetings, as needed.
The Education Committee is responsible for developing educational sessions that are presented at the beginning of the ASGCT Annual Meeting. The format of these sessions shall be determined through the guidance of the Program Committee co-chairs.
The Ethics Committee shall be responsible for making recommendations to the ASGCT Board of Directors on any position statements, or actions that the Society should take in relation to ethical issues in the field of gene and cell therapy. In addition, the committee shall be responsible for educating Society members on ethical issues. This education includes developing suggested programs for the ASGCT Annual Meeting and submitting them to the ASGCT Program Committee.
The Financial Affairs Committee recommends financial policies, reviews the Society’s annual budget, recommends the budget to the full board for approval, and monitors financial reports prepared by staff. The Financial Affairs Committee also provides oversight of the organization's annual financial audit.
The International Committee’s mission is to represent the international members of ASGCT within the Society. This representation includes the development of programs for the ASGCT Annual Meeting that highlight the work being done by gene and cell therapy investigators internationally. In addition, the committee will work to strengthen links between ASGCT and other international societies and gene and cell therapy centers.
The Membership Committee shall review all applications for membership in the Society and recommend their acceptance or rejection to the Board of Directors. In addition, this committee shall recommend various marketing strategies to increase the membership of ASGCT and to improve the retention rate of current ASGCT members.
The New Investigator Committee’s mission is to develop programs that support and engage students, post-doctoral fellows, and new investigators. Specifically, the Committee is asked to monitor and develop a mentorship program and leadership succession plan.
The Nominating Committee’s mission is to annually develop a list of candidates for election to the office of Vice-President, any vacancies in the offices of Secretary, Treasurer or Advisory Council member, and all vacancies for at-large director positions. The committee shall nominate at least two candidates for each of these offices. This list of nominees shall be submitted to the Secretary of the Society and then distributed to current members of the Society for a vote as outlined in the ASGCT Bylaws.
The Outreach and Communication Committee oversees Society activities designed to enhance interactions and communication with Members, the media, the public at large, and related organizations, including other societies, academic institutions, foundations, disease advocacy groups and industry. The Committee may also propose programs and strategies to the Board of Directors to enhance the visibility and stature of the Society. This Committee oversees society communications vehicles, including newsletters and the Society website, and advises the Board of Directors on programs to enhance communication and interactions between all relevant constituencies of the Society. This Committee may also propose programs to partner with related societies or other organizations to further the Society's mission.
The Program Committee shall be responsible for the overall development of the ASGCT Annual Meeting. The committee will have co-chairs with two year staggered terms and shall be appointed by the President-Elect. The Program Chair shall be in the second year of his/her respective term, and the co-chair shall be in the first year of his/her term. The Program co-chair will advance to Program chair in the second year, with the approval of the current President-Elect. The committee will annually request session suggestions for the ASGCT Annual Meeting from various standing committees and scientific committees of the ASGCT. The committee will make the final determination on the specific programs and speakers (workshops, symposia, etc.) that will be scheduled during the ASGCT Annual Meeting. The Program Committee will also determine the basic format for the Annual Meeting sessions, subject to the approval of the ASGCT President and Board of Directors.
The Publications Committee shall be responsible for taking action on behalf of the Society on issues related to publications including the overseeing of the Society’s journal, Molecular Therapy. The committee shall be involved in the selection of the Editor-in-Chief for Molecular Therapy, including the conducting interviews with candidates and making a recommendation to the ASGCT Board of Directors.
The various Scientific Committees are responsible for developing scientific symposia sessions that are presented at the ASGCT Annual Meeting. The format of these sessions shall be determined through the guidance of the Program Committee co-chairs.
The Translational Science and Product Development Committee exists to provide a forum for members to provide input and guidance to the Society's Board of Directors on matters pertaining to vector development and manufacturing technologies. The duties of the committee include recommending and organizing sessions and courses relevant to translational science and product development and providing input into draft guidance prepared by the Society. The Chair of the committee is appointed by the President-Elect.